| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/2007 | WO2007009682A1 Oral pharmaceutical formulations comprising substituted pyrazoline compounds |
| 01/25/2007 | WO2007009681A1 1 , 1-DIOXID0-2 , 3-DIHYDRO-l , 2-BENZISOTHIAZ0L-6-YL-1H-INDAZOL-4-YL-2 , 4-PYRIMIDINEDI AMINE DERIVATIVES |
| 01/25/2007 | WO2007009670A1 4-chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
| 01/25/2007 | WO2007009662A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 01/25/2007 | WO2007009657A1 Novel use of organic compounds |
| 01/25/2007 | WO2007009655A1 1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic |
| 01/25/2007 | WO2007009635A1 Phenyl substituted piperazine-derivatives as inhibitors of plaminogenic activator inhibitors-i (pai-i) |
| 01/25/2007 | WO2007009607A1 Novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders |
| 01/25/2007 | WO2007009601A1 Novel stabilized carotenoid compositions |
| 01/25/2007 | WO2007009578A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/25/2007 | WO2007009539A2 Use of inhibitors of histone deacetylases in combination with nsaid for the therapy of cancer and/or inflammatory diseases |
| 01/25/2007 | WO2007009524A1 2-arylbenzothiazoles and uses thereof |
| 01/25/2007 | WO2007009485A1 Substituted 8-phenoxy-y-carboline derivatives with 5ht1 activity |
| 01/25/2007 | WO2007009462A2 Treatment of migraine and headaches |
| 01/25/2007 | WO2007009397A1 Use of cymipristones for treating aids |
| 01/25/2007 | WO2007009395A1 Schisandrin b preparation |
| 01/25/2007 | WO2007009393A1 The use of chlorogenic acid in the manufacture of medicaments for increasing the effect of bone marrow cells |
| 01/25/2007 | WO2007009392A1 The use of chlorogenic acid in the manufacturing medicaments for treating and/or preventing hepatic injury |
| 01/25/2007 | WO2007009388A1 Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof |
| 01/25/2007 | WO2007009355A1 Paclitaxel injection and preparation method thereof |
| 01/25/2007 | WO2007009354A1 Pyrrolidine derivative intermediates,preparation and usage thereof |
| 01/25/2007 | WO2007009353A1 Substituted thiazol-4-one compounds, preparation methods and use thereof |
| 01/25/2007 | WO2007009326A1 A self-assembled and bistable quantum wire array of nano-medicine and its preparation process |
| 01/25/2007 | WO2007009320A1 A preparation of statins for prolonged release |
| 01/25/2007 | WO2007009265A1 NOVEL β-CYCLODEXTRIN-BASED MOLECULES AND DRUG DELIVERY COMPOSITIONS |
| 01/25/2007 | WO2007009264A1 Chemotherapeutic agents for inhibition of protein translation |
| 01/25/2007 | WO2007009245A1 Stabilized chlorite solutions in combination with fluoropyrimidines for cancer treatment. |
| 01/25/2007 | WO2007009236A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/25/2007 | WO2007009229A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates |
| 01/25/2007 | WO2007009227A1 Hepatitis c inhibitor peptide analogs |
| 01/25/2007 | WO2007009201A2 Process to obtain synthetic and semi-synthetic lignan derivatives, their antiparasitic activities and corresponding pharmaceutical formulations, including the therapeutic method using said lignan for the treatment of parasitosis |
| 01/25/2007 | WO2007009187A1 Polyphenol and probiotic containing nutritional supplement |
| 01/25/2007 | WO2007009164A1 Method of particle formation |
| 01/25/2007 | WO2007009146A1 Substituted 1-phenyl imidazoles as cox-i inhibitors |
| 01/25/2007 | WO2006131303A3 Peptide deformylase (pdf) inhibitors 4 |
| 01/25/2007 | WO2006130080A3 Quinoline derivatives as nk3 anatgonists |
| 01/25/2007 | WO2006128885A3 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation |
| 01/25/2007 | WO2006127368A3 Methods for synthesizing imidazotriazinones |
| 01/25/2007 | WO2006126082A3 Pyridine [3,4-b] pyrazinones as pde-5 inhibitors |
| 01/25/2007 | WO2006125977A3 Hybrid interfering rna |
| 01/25/2007 | WO2006125642B1 Methods and apparatus for transdermal or transmucosal application of testosterone |
| 01/25/2007 | WO2006124863A3 Pyrrolopyridine derivatives as protein kinase inhibitors |
| 01/25/2007 | WO2006122986A3 Use of penicillin-binding proteins or polynucleotides or antibodies thereof for preventing or treating bacterial infections |
| 01/25/2007 | WO2006122408A9 Bir domain binding compounds |
| 01/25/2007 | WO2006122254A3 Stable micronized candesartan cilexetil and methods for preparing thereof |
| 01/25/2007 | WO2006121861A3 Biphenylazetidinone cholesterol absorption inhibitors |
| 01/25/2007 | WO2006121467A3 Tetrahydrocarbazole derivatives for treating flaviridae viruses |
| 01/25/2007 | WO2006120682A3 Compositions and methods for treating hyperproliferative epidermal diseases |
| 01/25/2007 | WO2006119168A3 Use of carotenoids and/or carotenoid derivatives/analogs for reduction/inhibition of certain negative effects of cox inhibitors |
| 01/25/2007 | WO2006117696A3 Diastereoisomers of 4-hydroxyisoleucine and uses thereof |
| 01/25/2007 | WO2006117516A3 Topical compositions |
| 01/25/2007 | WO2006117400A3 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors |
| 01/25/2007 | WO2006114676A3 A process for the preparation of rupatadine |
| 01/25/2007 | WO2006113864A3 Oxindole compounds and their uses as therapeutic agents |
| 01/25/2007 | WO2006112961A3 Synergistic salivation components |
| 01/25/2007 | WO2006110654A8 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 01/25/2007 | WO2006110607A8 Methods for treating infectious disease exacerbated asthma |
| 01/25/2007 | WO2006110176A3 Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor |
| 01/25/2007 | WO2006108430A8 Nutrient composition comprising green tea polyphenols for treating osteosarcoma |
| 01/25/2007 | WO2006105112A3 Amino acid-containing composition for preventing or remedying in the skeletal muscle of aged people |
| 01/25/2007 | WO2006102494A3 Nanoparticulate corticosteroid and antihistamine formulations |
| 01/25/2007 | WO2006102345A3 Methods and systems for operating an aerosol generator |
| 01/25/2007 | WO2006101745A3 Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions |
| 01/25/2007 | WO2006096285A3 Compositions and methods for treating or preventing flaviviridae infections |
| 01/25/2007 | WO2006093774B1 Method of treatment of diarrhea-predominant ibs in a female subject receiving contraceptive therapy |
| 01/25/2007 | WO2006090376A3 Pharmaceutical compositions of the isolated d- enantiomer of the quinazolinone derivative halofuginone |
| 01/25/2007 | WO2006089298A3 Pyrimidine-fused diazepine derivatives and indole-fused pteridines |
| 01/25/2007 | WO2006086358A3 Mitotic kinesin inhibitors |
| 01/25/2007 | WO2006085144A3 Compositions containing high omega-3 and low saturated fatty acid levels |
| 01/25/2007 | WO2006084030A3 Small-molecule hsp90 inhibitors |
| 01/25/2007 | WO2006083949A3 Sepsis prevention through adenosine receptor modulation |
| 01/25/2007 | WO2006083869A3 Tumor necrosis factor inhibitors |
| 01/25/2007 | WO2006078948A3 Stable pharmaceutical formulations of zonisamide and methods for their manufacture |
| 01/25/2007 | WO2006078414A3 METHODS AND COMPOSITIONS CONCERNING siRNA'S AS MEDIATORS OF RNA INTERFERENCE |
| 01/25/2007 | WO2006074330A3 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/25/2007 | WO2006069805A3 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 01/25/2007 | WO2006066200A3 Solid forms of a chemokine receptor antagonist and methods of use thereof |
| 01/25/2007 | WO2006065277A3 Heterocyclic aspartyl protease inhibitors |
| 01/25/2007 | WO2006061428A3 Gaba-a alpha 2 and alpha 3 receptor agonists for treating neuropathic, inflammatory and migraine associated pain |
| 01/25/2007 | WO2006054304A3 Use of lipid conjugates in the treatment of disease |
| 01/25/2007 | WO2006050921A3 Preparation of telmisartan salts with improved solubility |
| 01/25/2007 | WO2006041874A3 Compounds for alzheimer's disease |
| 01/25/2007 | WO2006039212A3 Substituted 2h-1,3-benzoxazin-4(3h)-ones |
| 01/25/2007 | WO2006037016A3 Novel therapy for treatment of chronic degenerative brain diseases and nervous system injury |
| 01/25/2007 | WO2006033005A3 Thrombopoietin receptor agonists |
| 01/25/2007 | WO2006031799A3 Compositions comprising ubiquinones |
| 01/25/2007 | WO2006017545A3 Systems and methods for inhibiting metastasis |
| 01/25/2007 | WO2006015171A3 Use of glycosoaminoglycans for the prevention and treatment of sepsis |
| 01/25/2007 | WO2005123128A3 Methods for treating conditions associated with masp-2 dependent complement activation |
| 01/25/2007 | WO2005118777A8 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 01/25/2007 | WO2005102333A9 Methods of using and compositions comprising thalidomide for the treatment and management of pulmonary hypertension |
| 01/25/2007 | WO2005097125A3 Methods and compositions for the treatment, prevention or management of diysfunctional sleep and dysfunctional sleep associated with disease |
| 01/25/2007 | WO2005090336A8 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands |
| 01/25/2007 | WO2005065079A3 Medical implants and fibrosis-inducing agents |
| 01/25/2007 | WO2005025556A3 Antibiotic cycloalkyltetrahydroquinoline derivatives |
| 01/25/2007 | WO2004047844A8 Use of loxapine and amoxapine for the manufacture of a medicament for the treatment of pain |
| 01/25/2007 | US20070021619 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| 01/25/2007 | US20070021618 Crystal structure; hydrates; dissolvin gin solution; adding base; crystallization; salt formation |
| 01/25/2007 | US20070021617 Crystal structure; hydrates; dissolving in solution; adding base; crystallization; salt formation |
| 01/25/2007 | US20070021616 Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |